The availability of information on impaired renal function in the community pharmacy, a descriptive pilot study
For only 37% of patients with available information on impaired renal function in the PHARMO Database Network this information was also available in their community pharmacy. This was 52% when also risk medication was used. This was concluded in a study recently published in the Journal of Nephrology and Renal Therapy. In this study the availability of renal function tests in Dutch community pharmacies was assessed, using data on laboratory assessments in the PHARMO Database Network as golden standard. Findings suggest that available information on renal function in community pharmacies is insufficient, which hinders effective medication surveillance.
To read more, please click here.